1. Home
  2. OBDC vs AMRX Comparison

OBDC vs AMRX Comparison

Compare OBDC & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Owl Capital Corporation

OBDC

Blue Owl Capital Corporation

SELL

Current Price

$10.11

Market Cap

5.6B

Sector

Finance

ML Signal

SELL

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

SELL

Current Price

$19.94

Market Cap

6.4B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
OBDC
AMRX
Founded
2015
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
6.4B
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
OBDC
AMRX
Price
$10.11
$19.94
Analyst Decision
Buy
Strong Buy
Analyst Count
13
7
Target Price
$13.17
★ $22.71
AVG Volume (30 Days)
★ 3.5M
2.8M
Earning Date
11-04-2026
11-03-2026
Dividend Yield
★ 12.46%
N/A
EPS Growth
N/A
★ 157.89
EPS
0.08
★ 0.37
Revenue
N/A
N/A
Revenue This Year
N/A
$4.53
Revenue Next Year
N/A
$9.13
P/E Ratio
$126.31
★ $53.69
Revenue Growth
N/A
N/A
52 Week Low
$9.82
$9.56
52 Week High
$13.58
$21.18

Technical Indicators

Market Signals
Indicator
OBDC
AMRX
Relative Strength Index (RSI) 28.06 58.54
Support Level N/A $16.59
Resistance Level $11.37 $20.98
Average True Range (ATR) 0.18 0.68
MACD -0.05 -0.06
Stochastic Oscillator 23.53 58.34

Price Performance

Historical Comparison
OBDC
AMRX

About OBDC Blue Owl Capital Corporation

Blue Owl Capital Corp is a specialty finance company and business development company (BDC) focused on providing direct lending solutions to U.S. middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns, including senior secured, subordinated, or mezzanine loans and equity-related instruments. Its investment strategies are intended to generate favorable returns across credit cycles with an emphasis on preserving capital.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: